4//SEC Filing
Gandhi Mayank 4
Accession 0001209191-22-051466
CIK 0001828522other
Filed
Sep 27, 8:00 PM ET
Accepted
Sep 28, 4:47 PM ET
Size
5.5 KB
Accession
0001209191-22-051466
Insider Transaction Report
Form 4
Gandhi Mayank
Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-09-26+500,000→ 500,000 totalExercise: $0.56Exp: 2032-09-25→ Common Stock (500,000 underlying)
Footnotes (1)
- [F1]The stock option vests 25% on September 26, 2023, and in 36 monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.
Documents
Issuer
eFFECTOR Therapeutics, Inc.
CIK 0001828522
Entity typeother
Related Parties
1- filerCIK 0001832725
Filing Metadata
- Form type
- 4
- Filed
- Sep 27, 8:00 PM ET
- Accepted
- Sep 28, 4:47 PM ET
- Size
- 5.5 KB